Skip to main content
Caplight Logo









Biocogniv

Biocogniv

Private
Burlington, VermontHealthcare & Life Scienceshttps://biocogniv.com

Last Round

VC Round

Oct 19, 2023

Total Funding Raised

$6.42M

Company Overview

Biocogniv is a digital diagnostics company that develops artificial intelligence-powered technology for acute care settings to predict time-critical medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportpredictive AIsepsis detectionEHR integrationelectronic health recordEHRclinical analyticsmedical AIai healthcarehospital softwarediagnostic softwarereal-time clinical insightsacute care analyticsclinical workflow optimizationdigital diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biocogniv Comparables

Compare Biocogniv with similar companies based on industry and business-model similarity.

Biocogniv comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clew
86%
Bayesian Health
85%
Prenosis
85%

Biocogniv Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 19, 2023
SeedMar 16, 2022
GrantSep 1, 2020
AcceleratorAug 25, 2020

Key People

Founding team and executive leadership

Artur Adib

Founder, CEO

Founding Team

Steven Wallace

CTO, CISO

Executive Team

Biocogniv Investors

Notable investors and investment history

Biocogniv investors
InvestorRounds
Breyer CapitalSeed
NIH RADxGrant
Inflect HealthSeed
Promus VenturesSeed
Y CombinatorSeed, Accelerator
1984 VenturesSeed

Biocogniv Filings

Explore SEC and related filing metadata, where available.

Biocogniv filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biocogniv's valuation, stock price, and market status.

Is Biocogniv a public or private company?

Biocogniv is a private company.

What is the current stock price of Biocogniv?

Biocogniv is a private company with no public stock price. No recent secondary market data is available.

How much is Biocogniv worth (valuation)?

Valuation information for Biocogniv is not publicly available.

Can I buy Biocogniv stock?

Biocogniv shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biocogniv's last funding round?

Biocogniv's most recent funding round was VC Round on October 19, 2023.

Who are the main investors in Biocogniv?

Key investors in Biocogniv include Breyer Capital, Y Combinator.

Will Biocogniv IPO soon?

No public IPO plans have been announced for Biocogniv.

How can I track Biocogniv secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biocogniv's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlington, Vermont
Employee Range2
Year Founded2019
Last FundingOct 19, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?